Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma

SIMPLE SUMMARY: The standard of care for patients with newly diagnosed glioblastoma (GBM) comprises surgery followed by radio- and chemotherapy. In addition, dexamethasone is used to manage the development of inflammation within the brain in general, and particularly during treatment. The effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldaz, Paula, Auzmendi-Iriarte, Jaione, Durántez, Maika, Lasheras-Otero, Irene, Carrasco-Garcia, Estefania, Zelaya, M. Victoria, Bragado, Laura, Olías-Arjona, Ana, Egaña, Larraitz, Samprón, Nicolás, Morilla, Idoia, Redondo-Muñoz, Marta, Rico, Mikel, Squatrito, Massimo, Maria-Alonso, Marta, Fernández-Irigoyen, Joaquín, Santamaria, Enrique, Larráyoz, Iñaki M., Wellbrock, Claudia, Matheu, Ander, Arozarena, Imanol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836009/
https://www.ncbi.nlm.nih.gov/pubmed/33478100
http://dx.doi.org/10.3390/cancers13020361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836009/
https://www.ncbi.nlm.nih.gov/pubmed/33478100
http://dx.doi.org/10.3390/cancers13020361

Ejemplares similares